New York State Common Retirement Fund’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

New York State Common Retirement Fund’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,564	Closed	-$38.7K	–	3273
2023 Q4	$38.7K	Sell	9,564 -42	-0.4%	-$128	﹤0.01%	3058
2023 Q3	$25.8K	Buy	9,606 +72	+0.8%	+$282	﹤0.01%	3157
2023 Q2	$89K	Sell	9,534 -18	-0.2%	-$177	﹤0.01%	2950
2023 Q1	$84.8K	Buy	9,552 +1	+0%	+$10	﹤0.01%	2854
2022 Q4	$47.6K	Hold	9,551	–	–	﹤0.01%	3096
2022 Q3	$55K	Buy	9,551 +56	+0.6%	+$396	﹤0.01%	3124
2022 Q2	$53K	Hold	9,495	–	–	﹤0.01%	3213
2022 Q1	$109K	Buy	9,495 +7,844	+475%	+$83.8K	﹤0.01%	3003
2021 Q4	$21K	Buy	+1,651	New	+$24.9K	﹤0.01%	3296

New York State Common Retirement Fund's THRX Position: Q1 2024 in Review

New York State Common Retirement Fund sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 9,564 shares — an estimated $38.7K sold.

New York State Common Retirement Fund first reported a position in THRX in Q4 2021 and held it in 9 quarters. The position peaked at $109K in Q1 2022. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

New York State Common Retirement Fund reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
New York State Common Retirement Fund sold 9,564 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $38.7K.
New York State Common Retirement Fund first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
New York State Common Retirement Fund's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $109K in Q1 2022.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on New York State Common Retirement Fund's 13F filing for Q1 2024, filed 7 May 2024.